Global drug sales forecast to take a downturn
For the first time in 10 years global sales of pharmaceuticals are forecast by Evaluate to take a downturn because of growing pricing pressures.
Read More
Tag: pricing
Aspen Pharmacare hit by EU antitrust cancer drug price probe
European regulators will investigate pricing of five oncology treatments
Read More
Pharma firms accused of forming drug cartel
Concordia and Actavis UK stand accused of breaking UK competition law by artificially lifting the cost of hydrocortisone tablets to the National Health Service with a deal that delayed competition to the drug.
Read More
DH introduces Bill for new drug pricing controls
The Department of Health has introduced a new Bill in parliament that will enable the government to limit the cost of unbranded medicines in case of unreasonable price increases.
Read More
- Francis Crick Institute and Medicines Discovery Catapult open applications for next KQ Labs cohort
- Novartis receives European Commission approval for Itvisma for spinal muscular atrophy
- AlzeCure enters collaboration agreement with QuantumCell ApS for NeuroRestore project
- R1 Therapeutics forms advisory board to support advancement of AP306
- UAE launches first genomics-driven clinical trial to prevent Alzheimer’s disease
